Aventis Ketek

FDA requests additional data from Aventis on Ketek (telithromycin) in "approvable" letter for treatment of community acquired pneumonia, bacterial exacerbations of chronic bronchitis and acute bacterial sinusitis. Tonsillitis/pharyngitis indication is "not approvable," letter adds